US Stock MarketDetailed Quotes

NTLA Intellia Therapeutics

Watchlist
  • 16.060
  • +0.630+4.08%
Close Nov 6 16:00 ET
  • 16.340
  • +0.280+1.74%
Pre 08:18 ET
1.63BMarket Cap-2930P/E (TTM)

Intellia Therapeutics Stock Analyst Ratings & Price Target

Analyst Rating

Updated: Oct 31, 2024

Based on 20 analysts giving stock ratings to Intellia Therapeutics in the past 3 months

Strong Buy

  • Buy

    80.00%
  • Hold

    20.00%
  • Sell

    0.00%

Price Target

Updated: Oct 31, 2024

The average Intellia Therapeutics stock price target is 58.88 with a max estimate of 95.00 and a min estimate of 18.00

Detailed RatingsDetailed RatingsDetailed Ratings

Detailed Ratings

Receive timely notifications of rating changes

View more detailed ratings of institutions and analysts

View rating details page for historical data

Download APP

Analyst Ratings Disclaimer

Analysis

Analyst Rating

Updated: Oct 31, 2024

Strong Buy

  • Buy

    80.00%
  • Hold

    20.00%
  • Sell

    0.00%

Price Target

Updated: Oct 31, 2024

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data